Ginkgo Tree
Ginkgo biloba
a.k.a. Salisburia adiantifolia
“The Commission E approved the internal use of ginkgo for the following conditions:
“(a) For symptomatic treatment of disturbed performance in organic brain syndrome within the regimen of a therapeutic concept in cases of dementia syndromes with the following principal symptoms: memory deficits, disturbances in concentration, depressive emotional condition, dizziness, tinnitus, and headache. The primary target groups are demential syndromes, including primary degenerative dementia, vascular dementia, and mixed forms of both.
“Note: Before starting treatment with ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.
“(b) Improvement of pain-free walking distance in peripheral arterial occlusive disease in Stage II according to Fontaine (intermittent claudication) in a regimen of physical therapeutic measures, in particularly walking exercise.
“(c) Vertigo and tinnitus (ringing in the ear) of vascular and involutional origin.
“The World Health Organization reiterated the Commission E approved uses noted above, adding the following specific conditions to peripheral arterial occlusive disease: Raynaud’s disease (intermittent blue coloring of extremities due to restricted blood flow with no known direct cause, i.e., idiopathic, other than possible cold or emotion), acrocyanosis (i.e., Crocq’s disease: persistently poor circulation to hands and sometimes the feet, resulting in cold, blue, sweaty condition‚, and post phlebitis syndrome (painful swelling of veins).”
- Herbs for the Mind,
